Alpay AZAP, Hamdi AKAN, Günhan GÜRMAN, Mehmet ÖZEN

İnşaat Sırasında Hematoloji Bilim Dalında Alınan Koruyucu Önlemler

Amaç: İnşaat dönemleri, bağışıklık sistemleri baskılanmış hematoloji hastaları için invaziv fungal infeksiyonlar açısından yüksek risk taşımaktadır. Bu yazıda inşaat dönemindeki deneyimimizi paylaşmaktayız. Gereç ve Yöntem: Hastanemizin çok yakınında yapılan inşaat nedeniyle hematoloji hastalarında meydana gelebilecek infeksiyonların engellenmesi amacıyla yaptıklarımızı ve bunların sonuçlarını burada özetlemekteyiz. Bulgular: Hematoloji servisi ve kök hücre nakil ünitesinde tedavi edilen hastaların ve hastanenin fiziksel izolasyonu bu konuda esas önemli unsurlar olarak ortaya çıkmaktadır. Ayrıca yüksek riskli hastalarda ekstra önlem olarak antifungal profilaksi yararlıdır.Sonuç: Bu hastalarda infeksiyon kontrolünde risk odaklı multidisipliner bir yaklaşım etkin görünmekte ve infeksiyon kontrol ekibi de kritik bir rol oynamaktadır.

Protective Measures Against Infection During Construction in Hematology Patients

Aim: Construction periods have an increased risk for invasive fungal infections in immunosuppressive hematology patients. We share our experience during a construction period in this article. Material and Method: We summarize what we had performed to prevent infections in hematology patients due to the construction next to our department building in our hospital and the results. Results: The most important issues in this setting are physical isolation of the hospital building and the patients treated in hematology and stem cell transplantation unit. Antifungal prophylaxis is also beneficial as an additional precaution in high risk patients. Conclusion: Risk based multidisciplinary approach seems to be effective in these patients and infection control team play a critical role.

PDF

___

Clair JD, Colatrella S. Opening Pandora's (tool) Box: health care construction and as- sociated risk for nosocomial infection. Infect Disord Drug Targets. 2013;13:177-183.
Loo VG, Bertrand C, Dixon C, et al. Cont- rol of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol. 1996;17:360-364.
Haiduven D. Nosocomial aspergillosis and building construction. Med Mycol. 2009;47 Suppl 1:S210-216
Garnaud C, Brenier-Pinchart MP, Thie- baut-Bertrand A, ve ark. Seven-year sur- veillance of nosocomial invasive aspergil- losis in a French University Hospital. J Infect. 2012;65:559-567.
Berger J, Willinger B, Diab-Elschahawi M, et al. Effectiveness of preventive measures for hemato-oncologic patients undergoing stem cell transplantation during a period of hospital construction. Am J Infect Control. 2011;39:746-751.
Etancelin P, Silly S, Merle V, et al. Efficacy of a multidisciplinary team for preventing hospital-acquired invasive aspergillosis: five years' experience. Pathol Biol (Paris). 2009;57:71-75.
Klingspor L, Saaedi B, Ljungman P, Szakos A. Epidemiology and outcomes of patients with invasive mould infections: a retrospec- tive observational study from a single centre (2005-2009).Mycoses.2015; 58:470-477.
Neofytos D, Treadway S, Ostrander D, et al. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience. Transpl Infect Dis. 2013;15:233-242.
Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEI- FEM B-2004 study--Sorveglianza Epide- miologica Infezioni Fungine Nelle Emo- patie Maligne. Clin Infect Dis. 2007;45:1161-1170.
Bassetti M, Righi E. Overview of Fungal Infections--The Italian Experience. Semin Respir Crit Care Med. 2015;36:796-805.
Özen M, Yılmaz G, Coşkun B, ve ark. İn- şaat sırasında meydana gelebilecek hema- tolojik enfeksiyonların engellenmesi. In: İnfeksiyon dünyası çalıştayı (20-23 Mart 2014, Ankara) Kitabı. 2014: 21.
Holy O, Matousková I. The importance of cleanrooms for the treatment of haemato- oncological patients. Wspolczesna Onkol 2012;16: 266-272.
Özen M, Yılmaz G, Coşkun B, ve ark. A qu- asi-experimental study analyzing the effecti- veness of portable high efficiency particulate absorption filters in preventing infections in hematology patients during construction. Turk J Hematol 2016;33:41-47
Yılmaz Bozkurt G, Civriz Bozdag S, Top- cuoglu P, ve ark. Invasive fungal infections during a construction period. Bone Marrow Transplantation. 2011; 46(Suppl. 1): 232.
Koehler P, Cornely OA. Contemporary Strategies in the Prevention and Manage- ment of Fungal Infections. Infect Dis Clin North Am. 2015 Dec 28. pii: S0891- 5520(15)00092-6.
Ruhnke M, Arnold R, Gastmeier P. Infec- tion control issues in patients with haema- tological malignancies in the era of multid- rug-resistant bacteria. Lancet Oncol. 2014 Dec;15(13):e606-19.
Alothman A. Infection control and the im- munocompromised host. Saudi J Kidney Dis Transpl. 2005;16:547-555.
Simon A, Fleischhack G. Non-pharmaco- logic strategies to prevent and control in- fectious complications in pediatric hema- tology/oncology patients. Klin Padiatr. 2001 Sep;213 Suppl 1:A9-A21.
Godbole G, Gant V. Respiratory tract in- fections in the immunocompromised. Curr Opin Pulm Med. 2013;19:244-250.
Risi GF, Tomascak V. Prevention of infec- tion in the immunocompromised host, Am J Infect Control 1998;26:594-606.
Garner JS. Guideline for isolation precau- tion in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17: 53-80.
Oren I, Haddad N, Finkelstein R, Rowe JM. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemop- rophylaxis and institution of HEPA filters. Am J Hematol. 2001;66:257-262.
Menegueti MG, Ferreira LR, Silva MF, et al. Assessment of microbiological air qua- lity in hemato-oncology units and its rela- tionship with the occurrence of invasive fungal infections: an integrative review. Rev Soc Bras Med Trop. 2013;46:391-396.
Chang CC, Ananda-Rajah M, Belcastro A, et al. Consensus guidelines for implemen- tation of quality processes to prevent inva- sive fungal disease and enhanced surveil- lance measures during hospital building works, 2014. Intern Med J. 2014 Dec;44(12b):1389-1397.
Akan H, Antia VP, Kouba M, et al. Pre- venting invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects. J Anti- microb Chemother. 2013 Nov; 68 Suppl 3:iii5-16.
Kung HC, Johnson MD, Drew RH, et al. Clinical effectiveness of posaconazole ver- sus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retros- pective cohort study. Cancer Med. 2014;3:667-673.
Metan G, Türe Z, Pala Ç, et al. A Single Center Experience for Antifungal Prophylaxis in Patients with Acute Myelo- genous Leukemia. Indian J Hematol Blood Transfus. 2015;31:339-345.
Kidd F, Buttner C, Kressel AB. Construc- tion: a model program for infection cont- rol compliance. Am J Infect Control. 2007;35:347-350.
Centers for Disease Control and Preven- tion; Infectious Disease Society of Ame- rica; American Society of Blood and Mar- row Transplantation. Guidelines for pre- venting opportunistic infections among hematopoietic stem cell transplant recipi- ents. MMWR Recomm Rep. 2000 Oct;49(RR-10):1-125, CE1-7.
Tomblyn M, Chiller T, Einsele H, et al. Center for International Blood and Marrow Transplant Research (CIBMTR); National Marrow Donor Program (NMDP); European Blood and Marrow Transplant Group (EBMT); American Society of Blood and Marrow Transplantation (ASBMT); Canadian Blood and Marrow Transplant Group (CBMTG); Infectious Disease Society of America (IDSA); Society for Healthcare Epidemiology of America (SHEA); Association of Medical Microbiology and Infectious Diseases Canada (AMMI); Centers for Disease Control and Prevention (CDC). Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant. 2009; 44:453-558.